CH680649A5 - - Google Patents
Download PDFInfo
- Publication number
- CH680649A5 CH680649A5 CH182389A CH182389A CH680649A5 CH 680649 A5 CH680649 A5 CH 680649A5 CH 182389 A CH182389 A CH 182389A CH 182389 A CH182389 A CH 182389A CH 680649 A5 CH680649 A5 CH 680649A5
- Authority
- CH
- Switzerland
- Prior art keywords
- weight
- patients
- treatment
- anxiety
- vegetative
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 28
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 10
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 9
- 239000001138 artemisia absinthium Substances 0.000 claims description 9
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 8
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 8
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 8
- 208000020401 Depressive disease Diseases 0.000 claims description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 6
- 241000961922 Onosma Species 0.000 claims description 6
- 239000013521 mastic Substances 0.000 claims description 6
- 241000271309 Aquilaria crassna Species 0.000 claims description 5
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 5
- 240000002943 Elettaria cardamomum Species 0.000 claims description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 5
- 241000220317 Rosa Species 0.000 claims description 5
- 239000011425 bamboo Substances 0.000 claims description 5
- 235000005300 cardamomo Nutrition 0.000 claims description 5
- 244000182067 Fraxinus ornus Species 0.000 claims description 4
- 235000002917 Fraxinus ornus Nutrition 0.000 claims description 4
- 239000002249 anxiolytic agent Substances 0.000 claims description 4
- 230000000949 anxiolytic effect Effects 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 2
- 240000001851 Artemisia dracunculus Species 0.000 claims 1
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 description 23
- 230000036506 anxiety Effects 0.000 description 20
- 239000000126 substance Substances 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 10
- 240000002877 Artemisia absinthium Species 0.000 description 9
- 239000002775 capsule Substances 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 7
- 239000000902 placebo Substances 0.000 description 7
- 229940068196 placebo Drugs 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 244000271437 Bambusa arundinacea Species 0.000 description 5
- 229940049706 benzodiazepine Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 208000019116 sleep disease Diseases 0.000 description 5
- 230000000392 somatic effect Effects 0.000 description 5
- VMIYHDSEFNYJSL-UHFFFAOYSA-N Bromazepam Chemical compound C12=CC(Br)=CC=C2NC(=O)CN=C1C1=CC=CC=N1 VMIYHDSEFNYJSL-UHFFFAOYSA-N 0.000 description 4
- 206010012374 Depressed mood Diseases 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001557 benzodiazepines Chemical class 0.000 description 4
- 230000003001 depressive effect Effects 0.000 description 4
- 229940124600 folk medicine Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 208000037490 Medically Unexplained Symptoms Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 229960002729 bromazepam Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000024714 major depressive disease Diseases 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010054089 Depressive symptom Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- -1 flavone glycoside Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 208000019899 phobic disease Diseases 0.000 description 2
- 208000024335 physical disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DZVXRFMREAADPP-UHFFFAOYSA-N thujyl alcohol Chemical compound CC1C(O)CC2(C(C)C)C1C2 DZVXRFMREAADPP-UHFFFAOYSA-N 0.000 description 2
- 230000003867 tiredness Effects 0.000 description 2
- 208000016255 tiredness Diseases 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- PZHWYURJZAPXAN-ILOFNVQHSA-N (+)-absinthin Chemical compound C([C@H]1[C@H](C)C(=O)O[C@@H]11)C[C@](C)(O)[C@@H]2[C@H]3[C@@H]4[C@H]5[C@@](C)(O)CC[C@H]6[C@H](C)C(=O)O[C@@H]6C5=C(C)[C@@H]4[C@]21C(C)=C3 PZHWYURJZAPXAN-ILOFNVQHSA-N 0.000 description 1
- CVULDJMCSSACEO-UHFFFAOYSA-N (-)-anabellamide Natural products C=1C=CC=CC=1CC(NC(=O)C=1C=CC=CC=1)C(=O)OCC(NC(=O)C=1C=CC=CC=1)CC1=CC=CC=C1 CVULDJMCSSACEO-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- GHODAOZUPBDHHO-UHFFFAOYSA-N 10',11'-epiabsinthin Natural products CC1CC2C3C4C(=C(C)C3C15C6OC(=O)C(C)C6CCC(C)(O)C25)C7OC(=O)C(C)C7CCC4(C)O GHODAOZUPBDHHO-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- SYTRJRUSWMMZLV-UHFFFAOYSA-N 4-epimatricin Natural products C1=CC(O)(C)C2C1=C(C)CC(OC(C)=O)C1C2OC(=O)C1C SYTRJRUSWMMZLV-UHFFFAOYSA-N 0.000 description 1
- PZHWYURJZAPXAN-UHFFFAOYSA-N Absynthin Natural products C12OC(=O)C(C)C2CCC(C)(O)C2C3C4C5C(C)(O)CCC6C(C)C(=O)OC6C5=C(C)C4C21C(C)=C3 PZHWYURJZAPXAN-UHFFFAOYSA-N 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 244000059800 Amomum compactum Species 0.000 description 1
- 235000016426 Amomum compactum Nutrition 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- OVZIMEDUADJHPN-BLQGRMASSA-N Anabsin Chemical compound C([C@]([C@H]12)(C)O3)C[C@H]4[C@H](C)C(=O)O[C@@H]4[C@@]22[C@]3(C)[C@@H](O)[C@@H]1[C@@H]1[C@H]3[C@@](C)(O)CC[C@H]4[C@H](C)C(=O)O[C@@H]4C3=C(C)[C@@H]12 OVZIMEDUADJHPN-BLQGRMASSA-N 0.000 description 1
- XDKZYFZYOVAAKJ-VXVJPEHISA-N Anabsinthin Chemical compound C([C@]([C@H]12)(C)O3)C[C@H]4[C@H](C)C(=O)O[C@@H]4[C@@]22[C@]3(C)C[C@@H]1[C@@H]1[C@H]3[C@@](C)(O)CC[C@H]4[C@H](C)C(=O)O[C@@H]4C3=C(C)[C@@H]12 XDKZYFZYOVAAKJ-VXVJPEHISA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 208000027559 Appetite disease Diseases 0.000 description 1
- BXBCLQRTBGRRDB-UHFFFAOYSA-N Artabsin Natural products C1CC(C)(O)C2=CCC(C)=C2C2OC(=O)C(C)C21 BXBCLQRTBGRRDB-UHFFFAOYSA-N 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000209128 Bambusa Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010065369 Burnout syndrome Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001510312 Elettaria Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 206010049708 Feeling guilty Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001916 Hypochondriasis Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- SYTRJRUSWMMZLV-VQGWEXQJSA-N Matricin Chemical compound [C@@H]1([C@H](CC(C)=C2[C@@H]3[C@](C=C2)(C)O)OC(C)=O)[C@@H]3OC(=O)[C@H]1C SYTRJRUSWMMZLV-VQGWEXQJSA-N 0.000 description 1
- SYTRJRUSWMMZLV-AHWDLOTJSA-N Matricin Natural products O=C(O[C@@H]1[C@H]2[C@H](C)C(=O)O[C@@H]2[C@H]2[C@](O)(C)C=CC2=C(C)C1)C SYTRJRUSWMMZLV-AHWDLOTJSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229920000175 Pistacia lentiscus Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000016588 Rosa centifolia Nutrition 0.000 description 1
- 244000052585 Rosa centifolia Species 0.000 description 1
- 244000181025 Rosa gallica Species 0.000 description 1
- 235000000533 Rosa gallica Nutrition 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042458 Suicidal ideation Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 235000013323 absinthe Nutrition 0.000 description 1
- GMKDAIKQCOMFGO-UHFFFAOYSA-N absinthin Natural products CC1C2CCC(C)(O)C34C5CC(C)(C3C=C(C)C4C2OC1=O)C6=C5C(C)(O)CCC7C(C)C(=O)OC67 GMKDAIKQCOMFGO-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- BXBCLQRTBGRRDB-MJVIGCOGSA-N artabsin Chemical compound C1C[C@](C)(O)C2=CCC(C)=C2[C@H]2OC(=O)[C@@H](C)[C@@H]21 BXBCLQRTBGRRDB-MJVIGCOGSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 201000003104 endogenous depression Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 230000007510 mood change Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- 230000010490 psychological well-being Effects 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- XJKVPKYVPCWHFO-UHFFFAOYSA-N silicon;hydrate Chemical compound O.[Si] XJKVPKYVPCWHFO-UHFFFAOYSA-N 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003093 somatogenic effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19883820218 DE3820218A1 (de) | 1988-06-14 | 1988-06-14 | Phytotherapeutikum zur behandlung von depressivem syndrom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH680649A5 true CH680649A5 (enExample) | 1992-10-15 |
Family
ID=6356519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH182389A CH680649A5 (enExample) | 1988-06-14 | 1989-05-17 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0396638B1 (enExample) |
| CH (1) | CH680649A5 (enExample) |
| DE (1) | DE3820218A1 (enExample) |
| WO (1) | WO1989012454A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083476A (zh) * | 2014-07-24 | 2014-10-08 | 河南中医学院 | 一种玫瑰花提取物在制备抗抑郁药物中的应用 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4447588C2 (de) * | 1994-05-03 | 1997-11-20 | Omer Osama Dr Dr Med | Pflanzliches Arzneimittel zur Behandlung von chronischen und allergischen Rhino-Sino-Bronchitiden |
| DE19611078C2 (de) * | 1996-03-21 | 1997-10-02 | Osama L M Dr Med Dr Rer N Omer | Therapie von chronischen entzündlichen Darmerkrankungen mit einer Phytokombination |
| EP0909563A1 (de) * | 1997-10-17 | 1999-04-21 | OMER, Osama L. M., Dr.Dr. | Therapie von chronischen entzündlichen Darmerkrankungen mit einer Phytokombination |
| RU2223778C1 (ru) * | 2002-07-04 | 2004-02-20 | Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" | Биологически активная добавка "успокаивающие травы", обладающая общеукрепляющим и седативным действием |
| RU2220736C1 (ru) * | 2002-11-04 | 2004-01-10 | Андреева Татьяна Петровна | КОМПОЗИЦИЯ ИНГРЕДИЕНТОВ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОГО БАЛЬЗАМА "Гея-Венера Кос Пла" |
| DE20302508U1 (de) | 2003-02-13 | 2003-05-08 | Lautenbacher, Lutz, Dr., 82152 Planegg | Nahrungsergänzungsmittel für Haut, Haare, Nägel und Mineralstoffdefizite |
| PL2403505T3 (pl) | 2009-03-04 | 2017-06-30 | Regenera Pharma Ltd. | Terapeutyczne zastosowania frakcji gumy mastyksowej |
| EP2403512B1 (en) | 2009-03-04 | 2019-05-15 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
| CN108813614B (zh) * | 2018-06-13 | 2022-02-01 | 中国医学科学院药用植物研究所海南分所 | 一种沉香有效部位提取物抗焦虑抗抑郁的应用及其制备方法 |
| CN112704361A (zh) * | 2021-01-14 | 2021-04-27 | 程德广 | 一种帮助睡眠防抑郁功能的中药被子内套 |
| IT202100016712A1 (it) * | 2021-06-25 | 2022-12-25 | Pocket Natural Solutions S R L | Composizione funzionale di compresse orosolubili |
-
1988
- 1988-06-14 DE DE19883820218 patent/DE3820218A1/de active Granted
-
1989
- 1989-05-17 CH CH182389A patent/CH680649A5/de not_active IP Right Cessation
- 1989-06-10 WO PCT/DE1989/000381 patent/WO1989012454A1/de not_active Ceased
- 1989-06-10 EP EP19890906713 patent/EP0396638B1/de not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083476A (zh) * | 2014-07-24 | 2014-10-08 | 河南中医学院 | 一种玫瑰花提取物在制备抗抑郁药物中的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1989012454A1 (fr) | 1989-12-28 |
| DE3820218A1 (de) | 1989-12-28 |
| DE3820218C2 (enExample) | 1990-03-29 |
| EP0396638A1 (de) | 1990-11-14 |
| EP0396638B1 (de) | 1993-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5266318A (en) | Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed | |
| DE3705151C2 (enExample) | ||
| EP0396638B1 (de) | Heilpflanzengemisch für die behandlung von depressionen | |
| DE60001857T2 (de) | Verfahren zur behandlung von chronischer venöser insuffizienz mit einem extrakt aus blättern von roten weinreben | |
| DE60028377T2 (de) | Auf oregano basierende zusammensetzung | |
| EP0869807A2 (de) | Anwendung eines medikaments und verwendung eines stoffgemischs zur herstellung eines medikaments | |
| EP1980241B1 (de) | Feuchttücher zur Intimpflege für Frauen mit Vitex agnus-castus Extrakt | |
| DE102015102020A1 (de) | Immunologisch aktives Phyto-Gemisch und seine Anwendung bei der Prävention und in einem Verfahren zur Behandlung von Effloreszenzen | |
| EP0668768B1 (de) | Zusammensetzung zur bekämpfung von dermatomykosen und deren erregern sowie von schweissbildung und körpergeruch | |
| DE20109044U1 (de) | Pharmazeutische Zubereitung | |
| EP0331014A2 (de) | Verwendung von ACE-Inhibitoren für die Diabetesprophylaxe | |
| DE69513109T2 (de) | Holunder enthaltendes Hautpflegemittel | |
| KR20210075420A (ko) | 복합 천연추출물 함유 통증완화용 조성물 | |
| WO1991008750A1 (de) | Verwendung von pflanzenteilen der naturpflanze tinospora | |
| DE2720420A1 (de) | Wirkstoffkombination gegen sonnenerythem und diese enthaltendes arzneimittel | |
| DE3003036A1 (de) | Mittel zur verhinderung und beseitigung von glatzen | |
| EP1210945B1 (de) | Arzneimittelzubereitung mit antiarteriosklerotischer Wirkung | |
| DE4237551C1 (de) | Verwendung einer Zusammensetzung auf pflanzlicher Basis zur Bekämpfung von Dermatomykosen | |
| LU102656B1 (de) | Flüssiges Nahrungsergänzungsmittel zur Immunstimulation, Verfahren zu dessen Herstellung sowie Verwendung | |
| DE4244754C2 (de) | Bekämpfung der Erreger von Dermatomykosen in Bekleidungsstücken | |
| DE4304284A1 (de) | Deodorierendes Mittel | |
| DE102005046892A1 (de) | Zusammensetzung aus planzlichem Material und Verwendung derselben zur Herstellung eines Medikaments zur Behandlung von Übergewicht, Fettleibigkeit und Fettsucht | |
| DE4112824A1 (de) | Verwendung von nelkenoel zur behandlung von bph | |
| DE202022107141U1 (de) | Zusammensetzung zur Aktivierung und/oder Stimulierung des limbischen Systems, diese enthaltende Kapsel oder Tablette sowie deren Verwendung als Nahrungsergänzungsmittel oder Arzneimittel | |
| Dweck et al. | Medicinal and aromatic plants industrial profile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |